If no CD12 news this week, its cuz of the FDA.
Post# of 148166
Dr. Seethamraju's statement on Oct 7 that the "FDA is reviewing CD12 unblinded data" impacts the schedule if true.
The FDA is taking a big bite here, and it may take some time for them to chew through all of the issues.